je.st
news
Tag: fda approval
FDA Approval Pumps New Life Into Edwards Stock
2015-06-27 09:00:47| Biotech - Topix.net
With FDA approval for its new Sapien 3 artificial heart valve, Edwards Lifesciences is nearing a new buy point in a first-stage base. The maker of products to treat advanced cardiovascular disorders may also get a boost from the positive impact the Supreme Court's ObamaCare decision is having on medical and health care stocks.
Tags: life
stock
approval
edwards
Actavis receives Fda approval to market Natrelle Inspira round gel-filled textured breast implants
2015-06-05 10:55:50| Biotech - Topix.net
Actavis plc , which recently completed the acquisition of Allergan, Inc., today announced that the company has received approval from the U.S. Food and Drug Administration to market NATRELLE INSPIRA round gel-filled textured breast implants, offering women undergoing reconstruction, augmentation or revision surgery another breast shaping option for a customized result. The NATRELLE INSPIRA line of breast implants is designed for women who are interested in increased breast fullness.
Tags: market
round
approval
receives
FDA panel recommends approval for Vertex cystic fibrosis drug
2015-05-12 23:23:51| Biotech - Topix.net
Kate Marshall, 15 , was diagnosed with cystic fibrosis at the age of 7 months. She is flanked by brother Chase, 11, and cousin Bridgid Marshall.
Tags: panel
drug
approval
recommends
Lilly's CYRAMZA (ramucirumab) Receives Fourth FDA Approval
2015-04-27 05:33:40| drugdiscoveryonline Home Page
Eli Lilly and Company (NYSE: LLY) has received its fourth U.S. Food and Drug Administration (FDA) approval for CYRAMZA® (ramucirumab). CYRAMZA (ramucirumab injection 10 mg/mL solution) is now also indicated in combination with FOLFIRI (irinotecan, folinic acid, and 5-fluorouracil) chemotherapy for the treatment of patients with metastatic colorectal cancer (mCRC) with disease progression on or after prior therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine.
Tags: fourth
approval
receives
fda
Teva Announces FDA Approval Of ProAir RespiClick
2015-04-22 08:17:13| dairynetwork News Articles
Teva Pharmaceutical Industries Ltd., recently announced that the U.S. Food and Drug Administration (FDA) has approved ProAir RespiClick (albuterol sulfate) inhalation powder, a breath-actuated, multi-dose, dry-powder, short-acting beta-agonist (SABA) inhaler for the treatment or prevention of bronchospasm in patients 12 years of age and older with reversible obstructive airway disease; and for the prevention of exercise-induced bronchospasm (EIB) in patients 12 years of age and older
Tags: approval
announces
fda
teva
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] next »